Best Short Squeeze Play to Watch in May 2020

short squeeze play

A short squeeze play happens when a stock that is heavily shorted for various reasons shows sudden changes in share price, thus pushing short-sellers out of their positions. As the short-sellers are forced to exit their positions, this adds buying pressure to the shares, and the share price rises higher. Short-sellers who exit their positions are forced to buy their borrowed stock. Short-selling is a precarious investment play, and traders can easily fall into a short squeeze trap. Although this is a nightmare for short-sellers, it is nonetheless a huge opportunity for regular investors.

Here are four short squeeze play stocks that day traders might want to consider:

Best Short Squeeze Play to Watch in May 2020: Briggs & Stratton Corporation (NYSE:BGG)

Briggs & Stratton has a short float of 35.50%. The Wauwatosa-based company recently indicated that it will adjust its production following the coronavirus pandemic. Briggs indicated that it will cut production in some of its manufacturing facilities, and also temporarily close others. Similarly, the company has withdrawn its fiscal 2020 financial outlook because of growing economic uncertainty. The move is in response to supply chain challenges and declining demand that has been caused by the COVID-19 pandemic.

Although the manufacturer said that it is cutting production, it does have enough finished product inventory to help meet its global customer demand and support its dealers.

Corporate marketing VP Rick Carpenter stated that some of the company’s facilities have not been operating due to a lack of adequate inventory. Currently, its Sherill, New York, and Burleigh Street plants are still operational.

Best Short Squeeze Play to Watch in May 2020: Blue Apron Holdings Inc. (NYSE:APRN)

short squeeze play

Our second potential short squeeze play stock is APRN stock, which has significantly benefited from the coronavirus crisis. The meal-kit maker has a short float of 44.74%. Up until the coronavirus pandemic, Blue Apron was one of the worst-performing stocks on Wall Street. When the company went public in June 2017, its IPO price was $150, but as of February 2020, the shares were trading at $2, having dropped 99% since 2017.

>> 5 Hot Penny Stocks with Big Moves

The coronavirus pandemic has been a blessing in disguise for the company, which has seen its stock surge from $2 in February to around $30 at the end of March. With lockdowns, people are staying at home, and they are avoiding restaurants, which created an opportunity for meal-kit makers such as Blue Apron. When the company’s stock hit $30, management indicated that they had experienced a significant increase in demand in recent weeks. Going forward, the pandemic could revolutionize consumer behavior and could make meal-kit making services into a large, mainstream industry.

Best Short Squeeze Play to Watch in May 2020: Mallinckrodt (NYSE:MNK)

Mallinckrodt has a stock short float of 65.32%. Since mid-March, MNK stock has surged 165%. The stock’s trigger came after the company announced that it had signed agreements with institutional investors for the exchange of its 4.875% outstanding Senior Notes of $495 million due this year. The company exchanged the notes for 10% new First Lien Senior Notes that will be due by 2025. This gave Mallinckrodt some breathing space as it strives to even out its finances.

Recently, the company launched a rolling proposal for marketing application approval in the US for its regenerative skin tissue therapy, StrataGraft, for adults with deep thermal burns. The product tries to imitate normal human skin, and it has been developed to minimize autograft in adults with severe thermal burns.

Best Short Squeeze Play to Watch in May 2020: MiMedx Group Inc. (NASDAQ:MDXG)

short squeeze play

MiMedx Group is a wound care and therapeutic biologics company with a short float of 75.44%. Recently, the company announced that it had received approval from the Bank of America regarding an application for the Paycheck Protection Program credit facility as per the CARES Act. The company is expecting to receive loan funds at the end of this month. Similarly, MiMedx has reached an agreement to amend its Loan Agreement with Blue Torch Finance.

Earlier this month, the company announced that it had reached a settlement with the justice department regarding a probe on the correctness of commercial valuation of one of its products to the Veteran Affairs department about its Federal Supply Schedule agreement. The company didn’t admit to the allegations brought against it but agreed to settle the matter by paying $6.5 million to the justice department.

Key Takeaway

Short-selling is very risky, so short-sellers need to be keen to avoid being caught in a short squeeze play. As for regular investors, these kinds of plays may be exactly what they want to keep an eye out for.

>> Read More Short Squeeze Stocks

Featured image: Pixabay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.